Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia
NCT04502030Phase 3Completed
- Sponsor
- Octapharma
- Start
- Oct 2020
- Primary completion
- Sep 2025
- Modality
- Biologic
- Countries
- 12
01
Overview
A Phase 3 trial of intravenous immunoglobulin G in Infection, sponsored by Octapharma. Started Oct 2020; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
Infection
Beyond the preview
Go deeper on NCT04502030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04502030.